Dechert LLP is well-placed to advise clients engaged in major cross-border transactions, including assisting with patent strategies tied to deals. On the contentious front, the firm’s litigators represent clients in patent disputes tied to a variety of drugs, and are also well versed in handling MDLs and class actions arising out of product liability claims. Boston-based patent specialist Andrea Reid advises biotech and pharmaceutical clients on the management of their IP portfolios, offering a deep understanding of the drug discovery and development processes and leading the practice alongside New York’s David Rosenthal, who advises life sciences-focused investors on IPOs, secondary offerings and licensing matters. Also based in New York, litigator Katherine Helm handles a broad spectrum of patent-related disputes, representing both plaintiffs and defendants in infringement suits and tackling commercial issues including breach of contract and antitrust litigations.
Legal 500 redaktioneller Kommentar

Referenzen

Unabhängig vom Legal 500-Forschungsteam zusammengestellt.

  • 'The collective discipline, first-hand knowledge of particular issues and the patience to explain complex issues is what makes the team invaluable.'

Kernmandanten

  • 4E Therapeutics
  • AbbVie/Allergan
  • Aldeyra Therapeutics
  • argenx SE
  • Atlas Ventures
  • Bicycle Therapeutics
  • Biogen
  • Cerus Endovascular
  • Chiesi Farmaceutici S.p.A.
  • Dana-Farber Cancer Institute

Highlight-Mandate

  • Advised Nimbus Therapeutics’ on patent issues relating to highly selective, allosteric TYK2 inhibitor portfolio to address multiple immune-mediated diseases.
  • Represented GSK as lead counsel in connection with multidistrict and state court litigation alleging that Zantac, a type of heartburn medication, causes cancer as a result of the formation of the chemical NDMA.
  • Advised Chiesi Farmaceutici S.p.A. in its definitive agreement to acquire Amryt Pharma Plc in an all-cash transaction valued at US$1.48bn.

Anwält*innen

Partner*innen der nächsten Generation

Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.

Praxisleitung

Andrea Reid; David Rosenthal

Weitere Kernanwält*innen

Katherine Helm